Evidence map›Paper›PMID 41023702›Full record

ReviewBMC neurology2025

Acute and reversible dyskinesias secondary to lithium toxicity: case report and literature review.

Marco Falletti, Federica Di Flumeri, Alessandro Zampogna, Martina Patera, Giovanni Fabbrini, Antonio Suppa

Abstract readCase ReportsReview
In one paragraph

Review in BMC neurology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Marco FallettiDepartment of Human Neurosciences, Sapienza University of Rome, Viale dell'Università, 30, Rome, 00185, Italy.
Federica Di FlumeriDepartment of Human Neurosciences, Sapienza University of Rome, Viale dell'Università, 30, Rome, 00185, Italy.
Alessandro ZampognaDepartment of Human Neurosciences, Sapienza University of Rome, Viale dell'Università, 30, Rome, 00185, Italy.
Martina PateraDepartment of Human Neurosciences, Sapienza University of Rome, Viale dell'Università, 30, Rome, 00185, Italy.
Giovanni FabbriniDepartment of Human Neurosciences, Sapienza University of Rome, Viale dell'Università, 30, Rome, 00185, Italy.
Antonio SuppaDepartment of Human Neurosciences, Sapienza University of Rome, Viale dell'Università, 30, Rome, 00185, Italy. antonio.suppa@uniroma1.it.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundLithium can cause several neurological side effects, including altered consciousness, delirium, cerebellar symptoms, parkinsonism, and seizures. Also, dyskinesias can be a possible manifestation of lithium intoxication. The clinical picture of dyskinesias secondary to lithium intoxication is still unclear. CASE PRESENTATION: We here describe the case of a 75-year-old woman who developed acute and reversible dyskinesia manifesting as generalised chorea because of lithium intoxication. The patient had a medical history of bipolar disorder type 2 and at least 20 years of continuous lithium monotherapy (150 mg, 1 tablet 3 times/day). Dyskinesias were associated with a high serum lithium level of 2.15 mEq/L. Imaging and EEG showed no relevant abnormalities. On the sixth day after admission, dyskinesias faded away when the lithium serum level decreased to 0.4 mmol/L. When critically reviewing the existing literature, we found a total of 33 cases, with an average age of 59.7 years, predominantly female. In these cases, the average lithium peak at the onset of dyskinesia was 2.25 mEq/L, with symptoms typically appearing 4.2 days after reaching peak lithium levels. DISCUSSION: Lithium toxicity, even at therapeutic serum concentrations, may induce abrupt-onset dyskinesia in susceptible individuals, likely mediated by reversible functional disturbances within the basal ganglia.

Indexed as

Antimanic AgentsDyskinesia, Drug-InducedLithium CompoundsAgedBipolar DisorderFemaleHumansAntimanic AgentsLithium CompoundsAthetosisChoreaChoreoathetosisDyskinesiaLithiumLithium toxicity

Identifiers

PMID41023702
PMCPMC12481728

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.